Clinical Trials Logo

Clinical Trial Summary

The COVID-19 disease, caused by SARS-CoV-2 virus, started in December 2019 and created a pandemic with high mortality and morbidity. Since a fully proven treatment has not been developed, the efficacy of currently available treatments is being investigated. Famotidine, an H2Receptor blocker, is one of the drug treatments being investigated. In this study, we aimed to investigate the effect of Famotidine treatment on the clinic and mortality of Covid-19 patients treated in the intensive care unit.

Clinical Trial Description

The computer and written records of the patients followed in the Covid-19 Intensive Care Units of a research hospital during the pandemic process will be examined. Patients over the age of 18 who have SARS-CoV-2 mRNA detected by nasopharyngeal PCR (Polymeraze Chaine Reaction) will be included in the study. Patients with immunosuppression, end-stage renal disease, liver disease, G6PD deficiency, ALT/AST >5, long QT syndrome in ECG, diagnosed with psoriasis, porphyria, pregnant, and allergic reactions to famotidine or similar drugs were excluded from the study. Patients' age, gender, comorbidities, smoking and APACHE II score will be recorded. Patients who were administered Famotidine 160 mg/day PO or nasogastric and were not given this treatment since their admission to the intensive care unit will be compared. The primary outcome will be the need for invasive mechanical ventilation, intensive care mortality, and both. As a secondary outcome, serum markers indicating the severity of the disease (Leukocytes, lymphocytes, neutrophils/leukocytes, platelets, ferritin, CRP, D-Dimer, fibrinogen, procalcitonin, IL-6, troponin, creatinine, AST, ALT, P/F ratio and lactate) will be recorded. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05122208
Study type Observational
Source Istanbul Medeniyet University
Status Completed
Start date March 20, 2020
Completion date August 15, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05125874 - Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization N/A
Recruiting NCT05062681 - RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow Phase 4
Completed NCT04697030 - Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan
Not yet recruiting NCT05096832 - Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study Phase 3
Not yet recruiting NCT05077332 - LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) Phase 2
Not yet recruiting NCT05077969 - Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) Phase 2
Not yet recruiting NCT05085574 - Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1) Phase 2
Recruiting NCT05123573 - Self-Perceived in Medical Students Undergoing Distance Learning
Completed NCT04674644 - Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales N/A
Active, not recruiting NCT05098600 - The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
Not yet recruiting NCT05123755 - AV-001 for Hospitalized Patients With COVID-19 Disease Phase 2
Completed NCT04426266 - Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population
Active, not recruiting NCT04842734 - Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic N/A
Recruiting NCT04474444 - Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP)
Recruiting NCT04789499 - Smell in Covid-19 and Efficacy of Nasal Theophylline Phase 2
Not yet recruiting NCT05118763 - Intranasal INNA-051 for Prevention of COVID-19 in Adults Phase 2
Completed NCT04477473 - Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group
Enrolling by invitation NCT05104385 - Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences
Completed NCT05094687 - Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).
Recruiting NCT04940208 - Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit